CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Background
Adaptive cellular therapy (ACT), particularly chimeric antigen receptor (CAR)-T cell therapy, has been successful in the treatment of hemopoietic malignancies. However, poor trafficking of administered effector T cells to the tumor poses a …